Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Diaz-Montero CM, et al. Cancer Immunol Immunother. 2009 Jan;58(1):49-59. doi: 10.1007/s00262-008-0523-4. Epub 2008 Apr 30. Cancer Immunol Immunother. 2009. PMID: 18446337 Free PMC article.
Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8+ T cells from negative regulation by local IFN-γ.
Lin L, Rayman P, Pavicic PG Jr, Tannenbaum C, Hamilton T, Montero A, Ko J, Gastman B, Finke J, Ernstoff M, Diaz-Montero CM. Lin L, et al. Cancer Immunol Immunother. 2019 Mar;68(3):395-405. doi: 10.1007/s00262-018-2280-3. Epub 2018 Dec 14. Cancer Immunol Immunother. 2019. PMID: 30552459 Free PMC article.
Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
Bayraktar UD, Chen E, Bayraktar S, Sands LR, Marchetti F, Montero AJ, Rocha-Lima CM. Bayraktar UD, et al. Cancer. 2011 Jun 1;117(11):2364-70. doi: 10.1002/cncr.25720. Epub 2010 Dec 17. Cancer. 2011. PMID: 24048783
Myeloid-derived suppressor cells in cancer patients: a clinical perspective.
Montero AJ, Diaz-Montero CM, Kyriakopoulos CE, Bronte V, Mandruzzato S. Montero AJ, et al. J Immunother. 2012 Feb-Mar;35(2):107-15. doi: 10.1097/CJI.0b013e318242169f. J Immunother. 2012. PMID: 22306898 Review.
Leveraging combinatorial chemotherapy to improve outcomes in patients with pancreatic cancer.
Koniaris LG, Jin X, Montero AJ, Zimmers TA. Koniaris LG, et al. Cancer Biol Ther. 2010 Jul 1;10(1):108-9. doi: 10.4161/cbt.10.1.12450. Epub 2010 Jul 21. Cancer Biol Ther. 2010. PMID: 20581450 No abstract available.
The economic burden of metastatic breast cancer: a U.S. managed care perspective.
Montero AJ, Eapen S, Gorin B, Adler P. Montero AJ, et al. Breast Cancer Res Treat. 2012 Jul;134(2):815-22. doi: 10.1007/s10549-012-2097-2. Epub 2012 Jun 9. Breast Cancer Res Treat. 2012. PMID: 22684273
Successful use of biweekly gemcitabine plus nab-paclitaxel in two male patients with stage iv breast cancer: case reports and review of the literature.
Montero AJ, Talebi TN, Zhu Y, Branch KD, Goldsberry GT, Baker MK, Gluck S. Montero AJ, et al. Am J Ther. 2011 Jan;18(1):e12-8. doi: 10.1097/MJT.0b013e3181c219e2. Am J Ther. 2011. PMID: 20027107
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.
Esnaola NF, Chaudhary UB, O'Brien P, Garrett-Mayer E, Camp ER, Thomas MB, Cole DJ, Montero AJ, Hoffman BJ, Romagnuolo J, Orwat KP, Marshall DT. Esnaola NF, et al. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):837-44. doi: 10.1016/j.ijrobp.2013.12.030. Int J Radiat Oncol Biol Phys. 2014. PMID: 24606850 Free PMC article. Clinical Trial.
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers.
Santa-Maria CA, Kruse M, Raska P, Weiss M, Swoboda A, Mutonga MB, Abraham J, Jain S, Nanda R, Montero AJ. Santa-Maria CA, et al. Breast Cancer Res Treat. 2017 Nov;166(1):179-184. doi: 10.1007/s10549-017-4415-1. Epub 2017 Jul 27. Breast Cancer Res Treat. 2017. PMID: 28752189
93 results
Jump to page